PKO Investment Management Joint-Stock Co
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2059321
WARSAW, R9
Position in REGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,678,886
-$763,794 QoQ
Shares Held
5,900
+2.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#423
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PKO Investment Management Joint-Stock Co holds $12,619,311 across 6 Biotechnology names. REGN ranks #2 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,050 | $5,488,866 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
5,900 | $3,678,886 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,500 | $2,257,725 | |
| 4 | INSM |
INSMED Inc
|
5,100 | $543,762 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,200 | $412,016 | |
| 6 | INCY |
Incyte Corp
|
2,100 | $238,056 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,678,886 | 5,900 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $4,442,680 | 5,750 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,743,569 | 4,850 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,297,424 | 11,200 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $9,870,000 | 18,800 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $9,703,719 | 15,300 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $7,693,164 | 10,800 | Shares | Sole | 2025-03-13 | |
| 2024-09-30 | $840,992 | 800 | Shares | Sole | 2025-03-13 | |
| 2024-06-30 | $315,309 | 300 | Shares | Sole | 2025-03-13 | |
| 2024-03-31 | $288,747 | 300 | Shares | Sole | 2025-03-13 | |
| 2023-12-31 | $263,487 | 300 | Shares | Sole | 2025-03-13 | |
| 2023-09-30 | $246,888 | 300 | Shares | Sole | 2025-03-13 | |
| 2023-06-30 | $790,394 | 1,100 | Shares | Sole | 2025-03-13 | |
| 2023-03-31 | $164,334 | 200 | Shares | Sole | 2025-03-13 | |
| 2022-12-31 | $432,894 | 600 | Shares | Sole | 2025-03-13 | |
| 2022-09-30 | $413,322 | 600 | Shares | Sole | 2025-03-13 | |
| 2022-06-30 | $709,356 | 1,200 | Shares | Sole | 2025-03-13 | |
| 2022-03-31 | $838,104 | 1,200 | Shares | Sole | 2025-03-13 | |
| 2021-12-31 | $1,447,443 | 2,292 | Shares | Sole | 2025-03-13 | |
| 2021-09-30 | $423,626 | 700 | Shares | Sole | 2025-03-13 | |
| 2021-06-30 | $390,978 | 700 | Shares | Sole | 2025-03-13 | |
| 2021-03-31 | $331,198 | 700 | Shares | Sole | 2025-03-13 | |
| 2020-12-31 | $338,177 | 700 | Shares | Sole | 2025-03-13 | |
| 2020-09-30 | $391,846 | 700 | Shares | Sole | 2025-03-13 | |
| 2020-06-30 | $436,555 | 700 | Shares | Sole | 2025-03-13 | |
| 2020-03-31 | $341,803 | 700 | Shares | Sole | 2025-03-13 | |
| No filing history on record for this holder in this stock. | ||||||